Skip to main content

Table 3 Symptoms, complications and sequelae

From: Systematic review of invasive meningococcal disease epidemiology in the Eastern Mediterranean and North Africa region

a) Acute symptoms

Region

EM

NA

Country

Iran [106]

Iran [91]

Qatar [69]

Turkey [97]

Turkey [107]

Saudi Arabia [71]

Egypt [78]b

Morocco [104]

Population type

GP

GP

GP

GP

GP

P

GP

GP

Number of patients in study

3

68

25

65

7

105

203

35

Date range, year

2009–2011

1992–2002

1992–2008

2000–2005

1995–2003

February–April 2000

1998–2004

2011–2013

Age range, year

Children (0.5–10)

Children (0–13)

Children, adults (0–68)

Children (0.5–10)

Children, adults (15–60)

Adults (18–80)

Children, adults (0–75)

Children (0–13)

Symptoms

 Proportion of patients experiencing acute symptoms (%)

0.0–100

8.8–64.7

4.0–80.0

7.7–95.4

71.4

28.6

16.0–79.0

5.7–65.7

 Stiff neck

100

55.9

52.0

   

79

 

 Rash

0

64.7

28.0

 

71.4

28.6

16

65.7

 Fever

66.7

 

80.0

95.4

    

 Meningeal irritation syndromea

66.7

       

 Seizure

66.7

8.8

4.0–12.0

7.7

   

11.4

 Headache

 

55.9

48.0

   

66.0

31.4

 Vomiting

  

56.0

    

40.0

 Altered consciousness

  

48.0

27.7

    

 Diarrhoea

   

9.2

   

11.4

 Purpura

   

92.3

    

 Photophobia

      

37

 

 Neck pain

       

17.1

 Abdominal pain

       

5.7

 Lethargy

       

48.6

 Irritability

       

8.6

b) Complications at admission and acute complications

Region

EM

NA

Reference

Iran [91]

Turkey [97]

Morocco [104]

Population type

GP

GP

GP

Number of patients in study

68

65

35

Date range, year

1992–2002

2000–2005

2011–2013

Age range, year

Children (0–13)

Children (0.5–10)

Children (0–13)

Complications at admission and acute complications

 Proportion of patients experiencing complications at admission and acute complications (%)

2.9–38.2

3.1–38.5

11.4–54.3

 Septic shock

38.2

38.5

 

 Conjunctivitis

2.9

  

 Pericarditis

2.9

  

 Myocarditis

 

4.6

 

 Purpura fulminans

 

4.6

 

 Acute renal failure

 

3.1

 

 ARDS

 

3.1

 

 Arthralgia

  

11.4

 Hemodynamic disorder/sepsis

  

54.3

c) Post-discharge complications/sequelae

Region

EM

NA

Reference

Kuwait [93]

Kuwait [94]

Qatar [69]

Qatar [52]

Saudi Arabia [124]

Saudi Arabia [71]

Turkey [98]

Turkey [99]

Egypt [78]

Tunisia [89]

Population type

GP

GP

GP

GP

GP

P

GP

GP

GP

GP

Number of patients in study

30

10

25

2

37

105

2

15

203

79

Date range, year

2001–2003

2010–2014

1992–2008

1998–2000

1999–2001

February–April 2000

1994–2004

2012–2016

1998–2004

1997–2006

Age range, year

Children (0–12)

Children (0–12)

Children, adults (0–68)

Children, adults (0–100)

Children (0–5)

Adults (18–80)

Children (2–4)

Children (0–18)

Children, adults (0–75)

Children (0–13)

Post-discharge complications and sequelae

 Proportion of patients experiencing post-discharge complications/sequelae (%)

3.4

0

4.0–24.0

0

2.7

1

50

33.3

5

1.3–7.6

 Hearing impairment

3.4

        

3.8

 Motor palsy

3.4

         

 Aphasia

  

8.0

       

 Limb weakness

  

8.0

       

 Focal findings

  

16.0

       

 Cranial nerve palsy

  

4.0

    

33.3

  

 Amputation

      

50.0

  

1.3

 Neurological complication

        

5.0

 

Skin necrosis

         

7.6

Non-specific sequelae

 

0.0

24.0

0.0

2.7

1.0

    
  1. All studies are cross-sectional unless otherwise stated
  2. ARDS acute respiratory distress syndrome, EM Eastern Mediterranean region, GP general population, NA North Africa region, P pilgrims
  3. aMeningeal irritation syndrome encompasses Kernig’s sign and Brudzinski’s sign [123]
  4. bSurveillance study